{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:25:39Z","timestamp":1783074339281,"version":"3.54.6"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["British Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.bjoms.2014.11.008","type":"journal-article","created":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T11:32:43Z","timestamp":1418297563000},"page":"176-182","source":"Crossref","is-referenced-by-count":30,"title":["United Kingdom nationwide study of avascular necrosis of the jaws including bisphosphonate-related necrosis"],"prefix":"10.1016","volume":"53","author":[{"given":"S.N.","family":"Rogers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.O.A.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Randall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjoms.2014.11.008_bib0005","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/annonc\/mdm442","article-title":"Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel","volume":"19","author":"Aapro","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bjoms.2014.11.008_bib0010","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.bjoms.2014.11.008_bib0015","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","article-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases","volume":"23","author":"Saad","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bjoms.2014.11.008_bib0020","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jbspin.2007.05.003","article-title":"Thirteen cases of jaw osteonecrosis in patients on bisphosphonate therapy","volume":"75","author":"Vieillard","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.bjoms.2014.11.008_bib0025","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1902\/jop.2007.070104","article-title":"Intravenous bisphosphonate-associated osteonecrosis of the jaw","volume":"78","author":"Statz","year":"2007","journal-title":"J Periodontol"},{"key":"10.1016\/j.bjoms.2014.11.008_bib0030","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1177\/154405910708601101","article-title":"Osteonecrosis of the jaws and bisphosphonate therapy","volume":"86","author":"Ruggiero","year":"2007","journal-title":"J Dent Res"},{"key":"10.1016\/j.bjoms.2014.11.008_bib0035","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00198-007-0384-2","article-title":"Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome","volume":"18","author":"Yarom","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bjoms.2014.11.008_bib0040","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.tripleo.2006.10.010","article-title":"Osteonecrosis of the jaws associated with use of risedronate: report of 2 new cases","volume":"103","author":"Brooks","year":"2007","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.bjoms.2014.11.008_bib0045","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.reuma.2012.05.005","article-title":"Systematic literature review of bisphosphonates and osteonecrosis of the jaw in patients with osteoporosis","volume":"9","author":"Chamizo Carmona","year":"2013","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.bjoms.2014.11.008_bib0050","unstructured":"National Institute for Health and Care Excellence. NICE technology appraisals [TA161]. Alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women (amended). October 2008 (amended January 2010 and January 2011). Available at: http:\/\/guidance.nice.org.uk\/TA161\/Guidance\/pdf\/English."},{"key":"10.1016\/j.bjoms.2014.11.008_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta9220","article-title":"A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis","volume":"9","author":"Stevenson","year":"2005","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.bjoms.2014.11.008_bib0060","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.oraloncology.2012.03.028","article-title":"Bisphosphonate-related osteonecrosis of the jaws \u2013 a review","volume":"48","author":"K\u00fchl","year":"2012","journal-title":"Oral Oncol"},{"key":"10.1016\/j.bjoms.2014.11.008_bib0065","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.1038\/sj.bdj.2013.327","article-title":"A study of 225 patients on bisphosphonates presenting to the bisphosphonate clinic at King's College Hospital","volume":"214","author":"Taylor","year":"2013","journal-title":"Br Dent J"},{"key":"10.1016\/j.bjoms.2014.11.008_bib0070","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1093\/annonc\/mdm370","article-title":"A retrospective study assessing the incidence, risk factors and comorbidities of pamidronate-related necrosis of the jaws in multiple myeloma patients","volume":"18","author":"Jadu","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bjoms.2014.11.008_bib0075","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jcms.2011.05.003","article-title":"Bisphosphonate-related osteonecrosis of the jaws \u2013 characteristics, risk factors, clinical features, localization and impact on oncological treatment","volume":"40","author":"Otto","year":"2012","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.bjoms.2014.11.008_bib0080","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1016\/j.joms.2011.03.051","article-title":"Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan","volume":"69","author":"Urade","year":"2011","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.bjoms.2014.11.008_bib0085","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.joms.2013.06.221","article-title":"Osteonecrosis of the jaw in Sweden associated with the oral use of bisphosphonate","volume":"72","author":"Ulmner","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.bjoms.2014.11.008_bib0090","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.3899\/jrheum.100221","article-title":"Bisphosphonate-associated osteonecrosis of the jaw in Ontario: a survey of oral and maxillofacial surgeons","volume":"38","author":"Khan","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.bjoms.2014.11.008_bib0095","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00198-012-2042-6","article-title":"Defining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: prior work and current challenges","volume":"24","author":"Solomon","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bjoms.2014.11.008_bib0100","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.3109\/00016357.2013.764007","article-title":"Bisphosphonate-related osteonecrosis of the jaw in four Nordic countries and an indication of under-reporting","volume":"71","author":"Kr\u00fcger","year":"2013","journal-title":"Acta Odontol Scand"},{"key":"10.1016\/j.bjoms.2014.11.008_bib0105","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bjoms.2010.05.007","article-title":"Bisphosphonate osteonecrosis of the jaw \u2013 a literature review of UK policies versus international policies on bisphosphonates, risk factors and prevention","volume":"49","author":"Patel","year":"2011","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.bjoms.2014.11.008_bib0110","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bjoms.2010.08.005","article-title":"Bisphosphonate osteonecrosis of the jaw: a literature review of UK policies versus international policies on the management of bisphosphonate osteonecrosis of the jaw","volume":"49","author":"McLeod","year":"2011","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.bjoms.2014.11.008_bib0115","unstructured":"SNAP surveys. Available at: http:\/\/www.snapsurveys.com."},{"key":"10.1016\/j.bjoms.2014.11.008_bib0120","unstructured":"Public Health England. Population estimates. Available at: http:\/\/www.erpho.org.uk."},{"key":"10.1016\/j.bjoms.2014.11.008_bib0125","unstructured":"World Health Organization. Essential medicines and health products information portal. Available at: http:\/\/apps.who.int\/medicinedocs\/en\/d\/Js6168e\/4.6.html."},{"key":"10.1016\/j.bjoms.2014.11.008_bib0130","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.bjoms.2009.07.020","article-title":"A survey of consultant members of the British Association of Oral and Maxillofacial Surgeons regarding bisphosphonate-induced osteonecrosis of the jaws","volume":"47","author":"Rogers","year":"2009","journal-title":"Br J Oral Maxillofac Surg"}],"container-title":["British Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0266435614006627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0266435614006627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T02:56:08Z","timestamp":1538016968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0266435614006627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0266435614006627"],"URL":"https:\/\/doi.org\/10.1016\/j.bjoms.2014.11.008","relation":{},"ISSN":["0266-4356"],"issn-type":[{"value":"0266-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]}}}